Septic shock-3 vs 2: an analysis of the ALBIOS study
Abstract Background A reanalysis of the ALBIOS trial suggested that patients with septic shock - defined by vasopressor-dependent hypotension in the presence of severe sepsis (Shock-2) - had a survival benefit when treated with albumin. The new septic shock definition (Shock-3) added the criterion o...
Збережено в:
| Автори: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2018-09-01
|
| Серія: | Critical Care |
| Предмети: | |
| Онлайн доступ: | http://link.springer.com/article/10.1186/s13054-018-2169-8 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
